Afya Limited (AFYA) FinancialsAFYAFinancialAfya Limited

Afya Limited (AFYA) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Undergrad, accounting for 89.5% of total sales, equivalent to BRL 869.72M. Other significant revenue streams include Continuing Education and Medical practice solutions. Understanding this composition is critical for investors evaluating how AFYA navigates market cycles within the Schools, Colleges & Universities industry.

Evaluating the bottom line, Afya Limited maintains a gross margin of 61.59%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 30.64%, while the net margin is 20.71%. These profitability ratios, combined with a Return on Equity (ROE) of 16.49%, provide a clear picture of how effectively AFYA converts its operational activities into shareholder value.

In the context of the broader market, AFYA competes directly with industry leaders such as TRIP and APEI. With a market capitalization of $1.27B, it holds a leading position in the sector. When comparing efficiency, AFYA's gross margin of 61.59% stands against TRIP's 88.80% and APEI's 53.07%. Such benchmarking helps identify whether Afya Limited is trading at a premium or discount relative to its financial performance.

Afya has demonstrated solid financial performance with a gross margin of 68.93% in Q1 2026 and a net margin of 25.85%, showcasing effective cost management and profitability.